A股異動丨萬達信息漲近4% 中國人壽再度增持萬達信息 持股超15%
格隆匯10月21日丨萬達信息(300168.SZ)漲近4%,報15.04元,成交3.4億元,總市值165.4億元。

10月20日晚間,萬達信息發佈公告稱,2019年10月18日,中國人壽通過二級市場增持的方式增持上市公司1522100股股份。在本次權益變動完成後,中國人壽與其一致行動人合計持有上市公司164869445股股份,占上市公司股比的15.0259%,本次權益變動後上市公司的實際控制人不發生變更。近三個月,中國人壽每月都在增持萬達信息。自8月初至今,中國人壽及其一致行動人持有萬達信息的股份增加5個百分點,從10.0259%一路增至15.0259%。中國人壽表示,中國人壽及其一致行動人不排除未來12個月內繼續增持萬達信息的股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.